Delivery Order SPE2DR25D1109-SPE2DR26FFL2L
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Trokendi XR 100 mg capsules (30-count) under a firm fixed-price contract with a ceiling value of $2,726.20. This is a non-set-aside competitive award with an ultimate completion date of December 15, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Trokendi XR 100 mg capsules (30-count). The contract ceiling value is $1,304.52, with an ultimate completion date of May 13, 2025. This is a non-set-aside, competitively awarded delivery order that will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $7,551.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count bottles of Trokendi XR 100 mg capsules on January 12, 2026, with completion due by January 13, 2026. This award was made without a set-aside designation on a fully competitive basis. The contract represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026, which...
- The Defense Logistics Agency awarded a delivery order valued at $3,523.95 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 200 mg capsules (30-count packages). This non-competitive, firm fixed-price delivery order was awarded on January 21, 2026, with an ultimate completion date of January 22, 2026. The pharmaceutical products will be delivered to the Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters and primary distribution center. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,456.58 to Amerisourcebergen Drug Corp for the supply of Trokendi XR 100 mg capsules (30-count packages). This competitively awarded, firm fixed-price contract was executed on January 21, 2026, with an ultimate completion date of January 22, 2026, and represents a non-set-aside procurement. The work will be performed at Amerisourcebergen's corporate office location in Conshohocken, Pennsylvania. Amerisourcebergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $5,403.67 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 100 mg capsules (30-count) on July 11, 2025, with completion scheduled for July 14, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Trokendi XR 200 mg capsules (30-count) with a ceiling value of $4,581.65. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is set for ultimate completion by November 4, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Trokendi XR 50 mg capsules (30-count) with a contract value of $3,085.77. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The order is scheduled for completion by September 18, 2025, and will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a $29,860.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Trokendi XR 200 mg capsules (30-count units). The award was made without a set-aside designation through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location. This delivery order represents a child contract action under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Trokendi XR 200 mg capsules (30-count units) with a ceiling value of $1,026.44. This firm fixed-price delivery order, with an ultimate completion date of October 21, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's larger contract vehicle with the agency. The order will be performed at the contractor's corporate office location in...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFL2LDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of Trokendi XR 100 mg capsules (30-count) with a ceiling value of $3,369.96. This firm fixed-price delivery order, which must be completed by January 23, 2026, represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026). The award was not set aside for any specific business category, indicating full and open competition. The pharmaceutical products will be delivered to the contractor's location in Conshohocken, Pennsylvania, where the company maintains its corporate office and primary distribution operations. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor that serves as a critical supplier to the Department of Defense and other federal healthcare systems. The company's contract portfolio demonstrates extensive experience delivering medications across multiple therapeutic domains, including neurological treatments like Trokendi XR (topiramate extended-release), to support military healthcare programs worldwide. This delivery order exemplifies the routine pharmaceutical procurement through DLA's Medical Supply Chain that sustains military treatment facilities and veteran healthcare programs with essential prescription medications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 1/21/26 |